http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108697826-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d986d3b448b2adf84ef6218aa81d0d07
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-0017
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0019
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-0088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
filingDate 2017-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2baf4c7047e8ab6252275268f61475af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5635da07fff2a3ac1b6926cf0897b13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61c96c179f6c46f9b36631f1e26370c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a358704cfbcda852451227c6e319d28
publicationDate 2018-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108697826-A
titleOfInvention Catheter lock solution and catheter lock method
abstract Various embodiments of the present invention relate to catheter lock solutions and catheter lock methods using trisodium citrate and ethanol, particularly 4.0-15.0 wt/vol% trisodium citrate as an anticoagulant and/or antibacterial ingredients, and 15.0‑25.0 v/v % ethanol as an antimicrobial ingredient. The use of catheter lock solutions and catheter locks can reduce treatment failure during medical procedures using catheters to deliver therapy by at least significantly reducing the risks associated with bloodstream infection, catheter system dysfunction, emboli formation, patient discomfort, and patient disease . These benefits can be attributed in part to the synergistic antimicrobial effect of trisodium citrate and ethanol in solution, resulting in an effective catheter lock solution with minimal ethanol concentration.
priorityDate 2016-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6679870-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005215978-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID944
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409206349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451349547
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559357
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452729134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491140
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID573

Total number of triples: 44.